Industry in Spain welcomes new health minister as drug spending falls and hospital debt grows
This article was originally published in Scrip
Executive Summary
Spain's new conservative government, led by the Partido Popular (People's Party), has named Ana Mato as its new health minister. She comes to office as spending on drugs continues to plummet and the authorities owe pharmaceutical companies some €5.8 billion. Both Farmaindustria and AESEG, which represent R&D-based companies and generics firms respectively, will be seeking a meeting with the minister.
You may also be interested in...
Germany Confirms No Reimbursement Status For ‘Lifestyle’ Drug Wegovy
In Germany Novo Nordisk’s obesity drug Wegovy will remain excluded from reimbursement for obesity, unlike Rhythm’s Imcivree.
New HTA Evidence Guidelines In EU Could Spell Trouble For Advanced Therapy Companies
New guidelines that cast doubt over the use of single-arm and non-randomized studies are “discouraging” for rare disease patients and the advanced therapy sector, says ARM, the Alliance for Regenerative Medicines.
Germany Courts Clinical Trials With Regulator Reshuffle & New Federal Ethics Committee
Plans to rejig two regulators’ roles and streamline the ethics committee system have drawn some criticism.